Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
Neurocrine Biosciences, Inc. (NBIX) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Oct 30, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More NBIX filings
- 144
Filed Oct 30, 2026
- SC 13G/A
Filed Oct 15, 2026
- 3
Filed Oct 7, 2026
- 8-K
Filed Sep 28, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 15, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.